Table 1. Reported solvent or formulation of cisplatin used for in vitro studies in selected peer-reviewed scientific journals, stated as percentage of total (with number of reports in parentheses).
| Formulation | Cancer Research | Molecular Cancer Therapeutics | PLoS | Molecular Pharmacology | Journal of Pharmacology and Experimental Therapeutics |
|---|---|---|---|---|---|
| Not reported | 43 (15) | 37 (13) | 43 (15) | 26 (9) | 50 (14) |
| DMSO | 34 (12) | 20 (7) | 17 (6) | 11 (4) | 14 (4) |
| Water | - | 3 (1) | 11 (4) | 11 (4) | 7 (2) |
| Buffer | - | - | - | 3 (1) | - |
| DMF | - | 3 (1) | 3 (1) | 3 (1) | - |
| Cell media | - | - | 3 (1) | 6 (2) | - |
| Clinical | 14 (5) | 23 (8) | 17 (6) | 14 (5) | 11 (3) |
| Saline | 3 (1) | 11 (4) | - | 20 (7) | 14 (4) |
| PBS | 3 (1) | 3 (1) | 3 (1) | 6 (2) | 4 (1) |